Toll Free: 1-888-928-9744

Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update

Published: Mar 30, 2016 | Pages: 53 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Abbott Vascular Inc. (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories is a medical device company that research, develops, manufactures, and markets therapeutic solutions for the treatment of cardiac and vascular diseases. The company offers coronary intervention products including bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires and others; peripheral intervention products such as peripheral dilatation catheters, peripheral guide wires, peripheral stent systems and others. The company also offers vessel closure products including clip closure, suture-mediated closure and vessel closure accessories and others. It also offers product technology solutions for the customers. Abbott Vascular is headquartered in Santa Clara, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abbott Vascular Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents 
Table of Contents 2
List of Tables  4
List of Figures  6
Abbott Vascular Inc. Company Snapshot  7
Abbott Vascular Inc. Company Overview  7
Abbott Vascular Inc. Pipeline Products and Clinical Trials Overview  8
Abbott Vascular Inc. - Pipeline Analysis Overview  10
Key Facts  10
Abbott Vascular Inc. - Major Products and Services  11
Abbott Vascular Inc. Pipeline Products by Development Stage  12
Abbott Vascular Inc. Clinical Trials by Trial Status  14
Abbott Vascular Inc. Pipeline Products Overview  18
Absorb Bioresorbable Vascular Scaffold  18
Absorb Bioresorbable Vascular Scaffold Product Overview  18
Absorb Bioresorbable Vascular Scaffold Clinical Trial  19
AVJ-09-385 Everolimus Eluting Coronary Stent System  30
AVJ-09-385 Everolimus Eluting Coronary Stent System Product Overview  30
Chemical RDN System  31
Chemical RDN System Product Overview  31
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5)  32
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Product Overview  32
ESPRIT Bioresorbable Vascular Scaffold  33
ESPRIT Bioresorbable Vascular Scaffold Product Overview  33
Mitral Valve Replacement Device  34
Mitral Valve Replacement Device Product Overview  34
Next Generation Mitral Regurgitation System  35
Next Generation Mitral Regurgitation System Product Overview  35
Next Generation SUPERA Delivery System  36
Next Generation SUPERA Delivery System Product Overview  36
Second Generation Bioresorbable Vascular Scaffold  37
Second Generation Bioresorbable Vascular Scaffold Product Overview  37
Xience SBA Everolimus Eluting Coronary Stent System  38
Xience SBA Everolimus Eluting Coronary Stent System Product Overview  38
XIENCE Thinman DES  39
XIENCE Thinman DES Product Overview  39
ZoMaxx Drug Eluting Coronary Stent System  40
ZoMaxx Drug Eluting Coronary Stent System Product Overview  40
Abbott Vascular Inc. - Key Competitors  41
Abbott Vascular Inc. - Key Employees  42
Abbott Vascular Inc. - Locations And Subsidiaries  43
Head Office  43
Recent Developments  44
Abbott Vascular Inc., Recent Developments  44
Mar 15, 2016: Abbott's Absorb, the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee  44
Feb 26, 2016: Abbott Issues Voluntary Safety Notice on MitraClip Delivery System Deployment Process  44
Nov 03, 2015: Additional First Time Endovascular Clinical Trial Results Announced At VIVA15  45
Oct 12, 2015: Abbott's One-year Trial Of Absorb Heart Stent Successful  46
Sep 01, 2015: Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study  46
Jul 20, 2015: John Muir Health Among First Hospitals in Northern California to Offer Breakthrough Device for Patients with Debilitating Heart Valve Disease  48
May 19, 2015: Abbott Announces CE Mark For New Advancement Of Absorb Stent System For People With Heart Disease  48
Mar 18, 2015: Cooper Heart Institute Participating in Study of New Heart Valve Treatment  49
Mar 15, 2015: Abbott's MitraClip System Shown to Mend Hearts and Improve Lives in People in the United States  49
Feb 02, 2015: ISET 2015: Minimally Invasive Clip Can Repair Mitral Valve Regurgitation  50
Appendix  52
Methodology  52
About GlobalData  52
Contact Us  52
Disclaimer  52
List of Tables
Abbott Vascular Inc. Pipeline Products and Clinical Trials Overview  9
Abbott Vascular Inc. Pipeline Products by Equipment Type  9
Abbott Vascular Inc. Pipeline Products by Indication  10
Abbott Vascular Inc. Clinical Trials by Trial Status  10
Abbott Vascular Inc., Key Facts  11
Abbott Vascular Inc., Major Products and Services  12
Abbott Vascular Inc. Number of Pipeline Products by Development Stage  13
Abbott Vascular Inc. Pipeline Products Summary by Development Stage  14
Abbott Vascular Inc. Clinical Trials by Trial Status  15
Abbott Vascular Inc. Clinical Trials Summary  16
Absorb Bioresorbable Vascular Scaffold - Product Status  19
Absorb Bioresorbable Vascular Scaffold - Product Description  19
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects with de Novo Native Coronary Artery Lesions in Chinese Population  20
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold In the Treatment of Subjects with De Novo Native Coronary Artery Lesions  20
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions  21
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System (BVS EECSS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions  21
Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation to Compare the Safety, Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System Against XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Subjects with Ischemic Heart Disease Caused by de Novo Native Coronary Artery Lesions: ABSORB II Randomized Controlled Trial  21
Absorb Bioresorbable Vascular Scaffold - A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold  in the Treatment of Subjects with de Novo Native Coronary Artery Lesions: ABSORB EXTEND Clinical Investigation  22
Absorb Bioresorbable Vascular Scaffold - A Multicenter Prospective Natural History Study Using Multimodality Imaging in Patients with Acute Coronary Syndromes - PROSPECT II (Natural History Study), Combined with a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)  22
Absorb Bioresorbable Vascular Scaffold - A Post-market Registry of Patients with de Novo Lesions in Previously Untreated Vessels Treated with Absorb BVS  23
Absorb Bioresorbable Vascular Scaffold - A Prospective Evaluation of a Standardized Strategy for the Use of Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction -The BVS STEMI STRATEGY-IT Registry  23
Absorb Bioresorbable Vascular Scaffold - A Prospective, Randomized Trial of Synergy Bioresorbable Polymer Coated Stents Versus Absorb Bioresorbable Backbone Stents in Patients Undergoing Coronary Stenting (ISAR-RESORB)  24
Absorb Bioresorbable Vascular Scaffold - A Randomized Controlled Comparison of Optical Coherence Tomography Guidance and Angiography-only Guidance for Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffold  24
Absorb Bioresorbable Vascular Scaffold - Absorb Bioresorbable Scaffold and Drug Coated Balloon for Treatment of In-Stent-Restenosis  25
Absorb Bioresorbable Vascular Scaffold - ABSORB Bioresorbable Scaffold versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis  25
Absorb Bioresorbable Vascular Scaffold - ABSORB III RCT Pharmacokinetics (PK) Sub-study  25
Absorb Bioresorbable Vascular Scaffold - Amsterdam Investigator-initiated Absorb Strategy All-comers Trial (AIDA Trial) - A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold Strategy Versus the XIENCE Family (XIENCE PRIME or XIENCE Xpedition) Everolimus Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-comers  26
Absorb Bioresorbable Vascular Scaffold - Comparison of a Paclitaxel-coated Balloon Without Stent Implantation Against an Everolimus-eluting Bioresorbable Scaffold for Treatment of Stable Coronary Artery Disease: A Prospective Randomized Study Using Optical Coherence Tomography  26
Absorb Bioresorbable Vascular Scaffold - Comparison of the ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (Xience) in Acute ST-Elevation Myocardial Infarction  27
Absorb Bioresorbable Vascular Scaffold - Complex Bifurcation Lesions - A Randomized Comparison Between the AXXESS Device in Combination with Absorb BVS, and Modified T Stenting with Absorb BVS: An OCT Study  27
Absorb Bioresorbable Vascular Scaffold - Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms: a Multi-modality, Multi-specialty Collaborative Study (PERFECT Program)  28
Absorb Bioresorbable Vascular Scaffold - Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study  28
Absorb Bioresorbable Vascular Scaffold - German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold System in Patients with Coronary Artery Stenosis  29
Absorb Bioresorbable Vascular Scaffold - Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion: A Randomized H215O PET/CT Study  29
Absorb Bioresorbable Vascular Scaffold - Optimal Lesion Preparation with Non-compliant Balloons for the Implantation of Bioresorbable Vascular Scaffolds (BVS) -OPRENBIS Study  29
Absorb Bioresorbable Vascular Scaffold - Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)  30
Absorb Bioresorbable Vascular Scaffold - Real World Advanced Experience of Bioresorbable Scaffold by Smart Angioplasty Research Team (SMART REWARD)  30
Absorb Bioresorbable Vascular Scaffold - Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients with Internal Pudendal Artery-related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB)  30
AVJ-09-385 Everolimus Eluting Coronary Stent System - Product Status  31
AVJ-09-385 Everolimus Eluting Coronary Stent System - Product Description  31
Chemical RDN System - Product Status  32
Chemical RDN System - Product Description  32
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status  33
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description  33
ESPRIT Bioresorbable Vascular Scaffold - Product Status  34
ESPRIT Bioresorbable Vascular Scaffold - Product Description  34
Mitral Valve Replacement Device - Product Status  35
Mitral Valve Replacement Device - Product Description  35
Next Generation Mitral Regurgitation System - Product Status  36
Next Generation Mitral Regurgitation System - Product Description  36
Next Generation SUPERA Delivery System - Product Status  37
Next Generation SUPERA Delivery System - Product Description  37
Second Generation Bioresorbable Vascular Scaffold - Product Status  38
Second Generation Bioresorbable Vascular Scaffold - Product Description  38
Xience SBA Everolimus Eluting Coronary Stent System - Product Status  39
Xience SBA Everolimus Eluting Coronary Stent System - Product Description  39
XIENCE Thinman DES - Product Status  40
XIENCE Thinman DES - Product Description  40
ZoMaxx Drug Eluting Coronary Stent System - Product Status  41
ZoMaxx Drug Eluting Coronary Stent System - Product Description  41
Abbott Vascular Inc., Key Employees  43 


List of Figures
Abbott Vascular Inc. Pipeline Products by Equipment Type  10
Abbott Vascular Inc. Pipeline Products by Development Stage  13
Abbott Vascular Inc. Clinical Trials by Trial Status  15

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposable

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify